The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])

This study is ongoing, but not recruiting participants.

Study NCT00518102 Information provided by Ethicon, Inc.

First Received: August 16, 2007 Last Updated: May 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given